Effect of DHEA and metformin on corpus luteum in mice

Reproduction

Volumn 138, Issue 3, 2009, Pages 571-579

  Sander, Valeria A ^a   Facorro, Graciela B ^b   Piehl, Lidia ^b   Rubín De Celis, Emilio ^b   Motta, Alicia B ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; CATALASE; ESTRADIOL; HYDROXYL RADICAL; METFORMIN; PRASTERONE; PROGESTERONE; PROSTAGLANDIN E; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; SERIC GONADOTROPIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; LIPID PEROXIDATION; LUTEAL INSUFFICIENCY; LUTEOLYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS;

ANIMALS; CORPUS LUTEUM; DEHYDROEPIANDROSTERONE; DINOPROST; FEMALE; HYPERANDROGENISM; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; METFORMIN; MICE; MICE, INBRED BALB C; OVARY; OXIDATIVE STRESS; PREGNANCY; PROSTAGLANDINS E;

MUS;

EID: 70449435776     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-08-0325     Document Type: Article

References (63)

1. Agarwal A, Gupta S & Sharma R 2005 Role of oxidative stress in female reproduction. Reproductive Biology and Endocrinology 3 28. (Pubitemid 41522097)
2. Al-Gubory KH, Ceballos-Picot I, Nicole A, Bolifraud P, Germain G, Michaud M, Mayeur C & Blachier F 2005 Changes in activities of superoxide dismutase, nitric oxide synthase, glutathione-dependent enzymes and the incidence of apoptosis in sheep corpus luteum during the estrous cycle. Biochimica et Biophysica Acta 1725 348-357. (Pubitemid 41393530)
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 85 2434-2438. (Pubitemid 32269197)
4. Bonnefont-Rousselot D, Raji B, Walrand S, Gardegraves-Albert M, Jore D, Legrand A, Peynet J & Vasson MP 2003 An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 52 586-589. (Pubitemid 36896285)
5. Bonser J, Walker J, Purohit A, Reed M, Potter B, Willis D, Franks S & Mason H 2000 Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. Journal of Endocrinology 167 465-471. (Pubitemid 32047553)
6. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 72 248-253.
7. Duarte AI, Santos MS, Oliveira CR & Rego AC 2005 Insulin neuroprotection against oxidative stress in cortical neurons - involvement of uric acid and glutathione antioxidant defenses. Free Radical Biology & Medicine 39 876-889.
8. Elbeltagy K, Honda KI, Ozaki K, Misugi T, Tokuyama O, Kimura M, Kira Y & Ishiko O 2007 In vitro effect of dehydroepiandrosterone sulfate on steroid receptors, aromatase, cyclooxygenase-2 expression, and steroid hormone production in preovulatory human granulosa cells. Fertility and Sterility 88 1135-1142.
9. Elia E, Sander V, Luchetti CG, Solano ME, Di Girolamo G, Gonzalez C & Motta AB 2006 The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Molecular Human Reproduction 12 475-481. (Pubitemid 44288192)
10. Endo T, Yamamoto H & Tanaka S 1988 Effect of prostaglandins (PGs) on progesterone production by human cultured luteal cells and their ability of PGs production. Nippon Naibunpi Gakkai Zasshi 64 687-697.
11. Estevez A, Farina M, Franchi AM, Johnson C, Vega M & Motta AB 2004 Interleukin-1beta up-regulates nitrite production: effects on ovarian function. Nitric Oxide 10 92-100. (Pubitemid 38591618)
12. Fedorcsak P, Dale PO, Storeng R, Abyholm T & Tanbo T 2003 The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecological Endocrinology 17 207-214. (Pubitemid 36760721)
13. Franks S 1995 Polycystic ovary syndrome. New England Journal of Medicine 333 853-861.
14. Fridstrom M, Carlstrom K, Sjoblom P & Hillensjo T 1999 Effect of prednisolone on serum and follicular fluid androgen concentrations in women with polycystic ovary syndrome undergoing in-vitro fertilization. Human Reproduction 14 1440-1444. (Pubitemid 29265430)
15. Gadsby JE, Balapure AK, Britt JH & Fitz TA 1990 Prostaglandin F2a receptors on enzyme dissociated pig luteal cells throughout the estrous cycle. Endocrinology 126 787-795.
16. Garrel C, Ceballos-Picot I, Germain G & Al-Gubory KH 2007 Oxidative stress-inducible antioxidant adaptive response during prostaglandin F2alpha-induced luteal cell death in vivo. Free Radical Research 41 251-259. (Pubitemid 46404467)
17. Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD & Luisi M 2006 Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecological Endocrinology 22 627-635. (Pubitemid 44915729)
18. Glueck CJ, Wang P, Goldenberg N & Sieve-Smith L 2002 Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human Reproduction 17 2858-2864. (Pubitemid 35350902)
19. Hansel W 1996 Special topics in the theriogenology, no.2: the bovine corpus luteum. Theriogenology 45 1265-1428.
20. Harbone L, Fleming R, Lyall H, Sattar N & Norman J 2003 Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88 4116-4123. (Pubitemid 37153708)
21. Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A et al. 2001 Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biology of Reproduction 64 157-162. (Pubitemid 32044624)
22. Hurwitz A, Finci-Yeheskel Z, Milwidsky A & Mayer M 2002 Regulation of cyclooxygenase activity and progesterone production in the rat corpus luteum by inducible nitric oxide synthase. Reproduction 123 663-669. (Pubitemid 34498340)
23. Jakubowicz DJ, Essah PA, Seppala M, Jakubowicz S, Baillargeon JP, Koistinien R & Nestler JE 2004 Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during the first trimester of pregnancy. Journal of Clinical Endocrinology and Metabolism 89 833-839. (Pubitemid 38269899)
24. Joseph-Horne R, Mason H, Batty S, White D, Hillier S, Urquhart M & Franks S 2002 Luteal phase progesterone excretion in ovulatory women with polycystic ovaries. Human Reproduction 17 1459-1463. (Pubitemid 34661791)
25. Knickerbocker JJ, Wiltbank MC & Niswender GD 1988 Mechanisms of luteolysis in domestic livestock. Domestic Animal Endocrinology 5 91-107.
26. Kotwica J, Wróbel M & Młynarczuk J 2006 The influence of polychlorinated biphenyls (PCBs) and phytoestrogens in vitro on functioning of reproductive tract in cow. Reproductive Biology 1 189-194.
27. Lee MT, Anderson E & Lee GY 1991 Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anatomical Record 231 185-192.
28. Lee GY, Croop JM & Anderson E 1998 Multidrug resistance gene expression correlates with progesterone production in dehydroepiandrosterone- induced polycystic and equine chorionic gonadotropin-stimulated ovaries of prepubertal rats. Biology of Reproduction 59 330-337. (Pubitemid 28099096)
29. Lord JM, Flight IH & Norman RJ 2003 Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews 3 CD0033053.
30. Luchetti CG, Solano ME, Sander V, Barreiro-Arcos ML, Gonzalez C, Di Girolamo G, Chiocchio S, Cremaschi G & Motta AB 2004 Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. Journal of Reproductive Immunology 64 59-74. (Pubitemid 39642853)
31. Luchetti CG, Mikó E, Szekeres-Bartho J, Paz DA & Motta AB 2008 Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice. Journal of Steroid Biochemistry and Molecular Biology 111 200-207.
32. Lunn SF, Fraser HM & Mason HD 2002 Structure of the corpus luteum in the ovulatory polycystic ovary. Human Reproduction 17 111-117.
33. Manikkam M, Steckler TL, Welch KB, Inskeep EK & Padmanabhan V 2006 Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology 147 1997-2007.
34. Mansfield R, Galea R, Brincat M, Hole D & Mason H 2003 Metformin has direct effects on human ovarian steroidogenesis. Fertility and Sterility 79 956-962. (Pubitemid 36385020)
35. La Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F & De Leo V 2002 Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertility and Sterility 78 1234-1239. (Pubitemid 35463120)
36. McCracken JA, Custer EE & Lamsa JC 1999 Luteolysis: a neuroendocrine-mediated event. Physiological Reviews 79 263-323.
37. Meenakumari KJ, Agarwal S, Krishna A & Pandey LK 2004 Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome. Brazilian Journal of Medical and Biological Research 37 1637-1644. (Pubitemid 39549604)
38. Minegishi K, Tanaka M, Nishimura O, Tanigaki S, Miyakoshi K, Ishimoto H & Yoshimura Y 2002 Reactive oxygen species mediate leukocyte-endothelium interactions in prostaglandin F2alpha-induced luteolysis in rats. American Journal of Physiology. Endocrinology and Metabolism 283 E1308-E1315. (Pubitemid 35340639)
39. Misra HP & Fridovich I 1972 The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biochemistry 247 3170-3175.
40. Motta AB & Gimeno MAF 1997 Nitric oxide participates in the corpus luteum regression in ovaries isolated from pseudopregnant rats. Canadian Journal of Physiology and Pharmacology 75 1335-1339.
41. Motta A, Estevez A, Franchi A, Perez-Martinez S, Farina M, Ribeiro M, Lasserre A & Gimeno M 2001a Regulation of lipid peroxidation by nitric oxide and PGF2alpha during luteal regression in rats. Reproduction 121 631-637. (Pubitemid 32318455)
42. Motta AB, Estevez A, Tognetti T, Gimeno MA & Franchi AM 2001b Dual effects of nitric oxide in functional and regressing rat corpus luteum. Molecular Human Reproduction 7 43-47. (Pubitemid 32101763)
43. Palomba S, Orio F Jr, Nardo LG, Falbo A, Russo T, Corea D, Doldo P, Lombardi G, Tolino A, Colao A et al. 2004 Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 89 4801-4809. (Pubitemid 39391410)
44. Palomba S, Russo T, Orio F Jr, Falbo A, Manguso F, Cascella T, Tolino A, Carmina E, Colao A & Zullo F 2006 Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Human Reproduction 21 457-465. (Pubitemid 43159923)
45. Riley JC & Behrman HR 1991 Oxygen radicals and reactive oxygen species in reproduction. Proceedings of the Society for Experimental Biology and Medicine 198 781-791.
46. Ristimaki A, Jaatinen R & Ritvos O 1997 Regulation of prostaglandin F2 alpha receptor expression in cultured human granulosa-luteal cells. Endocrinology 138 191-195. (Pubitemid 27009423)
47. Sander V, Solano ME, Elia EM, Luchetti CG, Gonzalez C, Di Girolamo G & Motta AB 2005 The influence of aehydroepiandrosterone on rarly pregnancy in mice. Neuroimmunomodulation 12 285-292. (Pubitemid 41318211)
48. Sander V, Luchetti CG, Elia E, Solano ME, Di Girolamo G, Gonzalez G & Motta AB 2006 Role of the N,N′- dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction 131 591-602.
49. Sander VA, Piehl L, Pacorro GB, Rubín de Celis E & Motta AB 2008 Regulation of functional and regressing stages of corpus luteum development in mice. Role of reactive oxygen species. Reproduction, Fertility, and Development 20 760-769.
50. Sawada M & Carlson JC 1991 Rapid plasma membrane changes in superoxide radical formation, fluidity, and phospholipase A2 activity in the corpus luteum of the rat during induction of luteolysis. Endocrinology 128 2992-2998.
51. Solano ME, Sander VA, Elia E, Luchetti CG, Di Girolamo G, Gonzalez C & Motta AB 2006 Metformin prevents embryonic resorption induced by hyperandrogenization with dehydroepiandrosterone in mice. Reproduction, Fertility, and Development 18 533-544. (Pubitemid 43806922)
52. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M et al. 1997 Failure of parturition in mice lacking the prostaglandin F receptor. Science 277 681-683. (Pubitemid 27373912)
53. Sugino N, Shimamura K, Tamura H, Ono M, Nakamura Y & Kato H 1996 Involvement of stimulatory effect of prostaglandin F2 alpha on superoxide radical production by macrophages in corpus luteum regression. Nippon Sanka Fujinka Gakkai Zasshi 48 393-398. (Pubitemid 126451270)
54. Sugino N, Karube-Harada A, Taketani T, Sakata A & Nakamura Y 2004 Withdrawal of ovarian seroids stimulates prostaglandin F2a production through nuclear factor-kappa B activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. Journal of Reproduction and Development 50 215-225. (Pubitemid 40631821)
55. Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, Nose E, Morimoto C, Harada M, Koga K et al. 2007 Metformin suppresses interleukin (IL)-1β-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 92 3213-3218. (Pubitemid 47236394)
56. Tam NN, Ghatak S & Ho S 2003 Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of noble rats. Prostate 55 1-8. (Pubitemid 36397739)
57. Tosca L, Crochet S, Ferre P, Foufelle F, Tesseraud S & Dupont J 2006a AMP-activated protein kinase activation modulates progesterone secretion in granulosa cells from hen preovulatory follicles. Journal of Endocrinology 190 85-97. (Pubitemid 44161064)
58. Tosca L, Solnais P, Ferre P, Foufelle F & Dupont J 2006b Metformin-induced stimulation of adenosine monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biology of Reproduction 75 342-351. (Pubitemid 44268068)
59. Vrbíková J, Hill M, Stárka L, Cibula D, Bendlová B, Vondra K, Sulcová J & Snajderová M 2001 The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. European Journal of Endocrinology 144 619-628. (Pubitemid 32514817)
60. Wang HZ, Wu YF, Shen WX, Zhon W & Gong YT 1991 The hormonal control of human luteal cells. In Growth Factor in Fertility Regulation, pp 99-113. Eds FP Hasseltine & JK Findley. New York: Cambridge University Press.
61. Weems YS, Bridges PJ, Tanaka Y, Sasser RG, LeaMaster BR, Vincent DL & Weems CW 1997 PGE1 or PGE2 not LH regulates secretion of progesterone in vitro by the 88-90 day ovine corpus luteum of pregnancy. Prostaglandins 53 337-353. (Pubitemid 27306568)
62. Wiltbank MC & Ottobre JS 2003 Regulation of intraluteal production of prostaglandins. Reproductive Biology and Endocrinology 10 1-91.
63. Yuen KH & Peh KK 1998 Simple high-performance liquid chromatographic method for the determination of metformin in human plasma. Journal of Chromatography. B, Biomedical Sciences and Applications 710 243-246. (Pubitemid 28318161)